Sector Investors News and Insights

ALVO

ETFsector.com Daily Trading Outlook

November 4, 2025 S&P futures -1.0% in early Tuesday trading after U.S. equities ended mixed Monday, with narrow breadth again the dominant theme — over 60% of S&P 500 components declined even as Big Tech outperformed on AI partnership headlines. Overseas markets are weaker: Asia saw sharp declines (South Korea -2.5%, Japan -1.7%) and Europe […]

ETFsector.com Daily Trading Outlook Read More »

, , , , , , , , , , , , , , , , , , , , , , , , ,

ETFsector.com Daily Trading Outlook

October 16, 2025 S&P futures +0.4% in Thursday morning trading, following a mixed but mostly higher session on Wednesday that saw short baskets, non-profitable tech, large banks, dollar stores, auto suppliers, and industrial metals lead the market. Regional banks, industrial distributors, trucking, aerospace & defense, insurance, and staples lagged, while big tech was generally weaker.

ETFsector.com Daily Trading Outlook Read More »

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

ETFsector.com Daily Trading Outlook

October 15, 2025 S&P futures +0.6% in Wednesday morning trading, led by NVDA and TSLA. Follows Tuesday’s mixed close, with small caps, cyclicals, and banks outperforming while big tech lagged. Asian markets up over 1%, led by Japan, Hong Kong, and China; Europe higher with France leading on LVMH earnings and pension reform suspension. Treasuries

ETFsector.com Daily Trading Outlook Read More »

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Alvotech and Dr. Reddy’s have partnered up to launch AVT03, a biosimilar of Prolia and Xgeva, in the United States, Europe, and the United Kingdom.

Alvotech, a biotech company that focuses on creating biosimilar drugs for patients around the world, has teamed up with Dr. Reddys Laboratories SA.

Alvotech and Dr. Reddy’s have partnered up to launch AVT03, a biosimilar of Prolia and Xgeva, in the United States, Europe, and the United Kingdom. Read More »

,
Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com

If you haven’t received your newsletter email, check your spam/junk folder and add us to your contacts to ensure delivery.